Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Terri Katz
Regulatory Coordinator I
Cancer Center Division
Overview
Research
More
Collaboration
(14)
Linda Garland
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Abhijeet Kumar
Mutual work: 5 Proposals﹒4 Grants
Collaboration Details
Jennifer Segar
Mutual work: 2 Proposals﹒2 Grants
Collaboration Details
Gregory Woodhead
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Shamar Young
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Page 1 of 3
Previous page
Next page
Grants
(4)
Beamion PANTUMOR-1: A Phase II, Multicentre, Multicohort, Open-label Trial to Evaluate the Efficacy and Safety of Oral Zongertinib (BI 1810631) for the Treatment of Selected HER2-Mutated or Overexpres
Active
·
2024
·
$0 / $769.7K
·
External
clinical trial,
cancer treatment,
drug efficacy,
safety evaluation
Brightline-4: A Phase III Open-label, Single-arm, Multi-center Study to Assess the Safety and Efficacy of Brigimadlin (BI 907828) Treatment in Patients With Treatment -na?ve or Pre-treated Advanced D
Active
·
2024
·
$0 / $503K
·
External
pharmacology,
clinical trials,
oncology,
drug safety,
medical research
A First-in-human, Multicenter, Open-label, Dose Escalation and Dose Expansion Phase 1 Study in Patients with Advanced Solid Tumors to Evaluate the Safety of Intravenously Administered ALG.APV-527
Active
·
2024
·
$0 / $348.6K
·
External
cancer,
drug development,
clinical trial,
immunotherapy,
precision medicine
Phase 1 Study of Intratumoral Administration of VAX014 in Subjects with Advanced Solid Tumors
Active
·
2023
·
$0 / $352.4K
·
External
cancer immunotherapy,
clinical trial,
tumor microenvironment,
intratumoral therapy,
solid tumors
